grafts ameliorate whole body asymmetry and sensory neglect but not
independent limb use in rats with 6-hydroxydopamine lesions. Brain
Res 415:63–78.
Dunnett SB, Rogers DC, Richards SJ (1989) Nigrostriatal reconstruction
after 6-OH DA lesions in rats: combination of dopamine rich nigral
grafts and nigrostriatal “bridge” grafts. E xp Brain Res 75:523–535.
Engele J, Franke B (1996) Effects of glial cell line-derived neurotrophic
factor (GDN F) on dopaminergic neurons require concurrent activation
of cAM P-dependent signaling pathways. C ell Tissue Res 286:235–240.
Fawcett JW, Barker RA, Dunnett SB (1995) Survival of embryonic
mesencephalic dopaminergic neurones in explant, three-dimensional
and monolayer cultures, and the effects of bFGF. E xp Brain Res
106:275–282.
Freed WJ (1991) Substantia nigra grafts and Parkinson's disease: from
animal experiments to human therapeutic trials. Restor Neurol Neurosci 3:109 –134.
Gage FH, Stenevi U, Carlstedt T, Foster G, Bjo ̈rklund A, Aguayo AJ
(1985) Anatomical and functional consequences of grafting mesencephalic neurons into a peripheral nerve bridge connected to the denervated striatum. E xp Brain Res 60:584 –589.
Gundersen HJG, Jensen EB (1987) The efficiency of systematic sampling
in stereology and its prediction. J Microsc 147:229 –263.
Hammarberg H, Piehl F, Cullheim S, Fjell J, Hokfelt T, Fried K (1996)
GDNF mRNA in Schwann cells and DRG satellite cells after chronic
sciatic nerve injury. NeuroReport 7:857– 860.
Henderson CE, Phillips HS, Pollock R A, Davies AM, Lemeulle C,
Armanini M, Simpson LC, Moffet B, Vandlen RA, Koliatsos VE,
Rosenthal A (1994) GDN F: a potent survival factor for motoneurons
present in peripheral nerve and muscle. Science 266:1062–1064.
Heumann R, Lindholm D, Bandtlow C, Meyer M, Radeke MJ, Misko TP,
Shooter E, Thoenen H (1987) Differential regulation of mRNA en- coding nerve growth factor and its receptor in rat sciatic nerve during
development, degeneration, and regeneration: role of macrophages.
Proc Natl Acad Sci USA 84:8735– 8739.
Ide C, Tohyama K , Yokota R, Nitatori T, Onodepa H (1983) Schwann
cell basal lamina and nerve regeneration. Brain Res 288:61– 65.
Johansson M, Friedemann M, Hoffer B, Stromberg I (1995) Effects of
glial-cell line-derived neurotrophic factor on developing and mature
ventral mesencephalic grafts in oculo. E xp Neurol 134:25–34.
Kordower JH, Freeman TB, Snow BJ, Vingerhoets FJG, Mufson EJ,
Sanberg PR, Rosenstein JM, Collier TJ, Olanow C W (1995) L ongterm fetal nigral graft survival and putamenal innervation correlates
with functional recovery in a patient with Parkinson's disease—a
clinical pathological analysis. E xp Neurol 135:166.
Kromer L F, Cornbrooks C J (1985) Transplants of Schwann cell cultures
promote axonal regeneration in the adult mammalian brain. Proc Natl
Acad Sci USA 82:6330 – 6334.
Lapchak PA, Jiao S, Collins F, Miller PJ (1997) Glial cell line-derived
neurotrophic factor: distribution and pharmacology in the rat following
a bolus intraventricular injection. Brain Res 747:92–102.
Lee DA, Zurawel RH, Windebank AJ (1995) C iliary neurotrophic factor expression in Schwann cells is induced by axonal contact. J Neurochem 65:564 –568.
Leroy A, Michelet D, Mahieux F, Geny C, Defer G, Monfort JC, Degos
JD, Nguyen JP, Peschanski M, C esaro P (1996) Neuropsychological
assessment of 5 parkinsonian patients before and after neuronal graft.
Rev Neurol (Paris) 152:158 –164.
Lin LFH, Doherty DH, Lile JD, Bektesh S, Collins F (1993) GDNF—a
glial-cell line derived neurotrophic factor for midbrain dopaminergic
neurons. Science 260:1130 –1132.
Lindholm D, Heumann R, Meyer M, Thoenen H (1987) Interleukin-1
regulates synthesis of nerve growth factor in non-neuronal cells of rat
sciatic nerve. Nature 330:658 – 659.
Lindvall O (1997) Neural transplantation: a hope for patients with Parkinson's disease. NeuroReport 8:3– 8.
Lindvall O, Brundin P, Widner H, Rehncrona S, Gustavii B, Frackowiak
R, Leenders KL, Sawle G, Rothwell JC, Marsden CD, Bjo ̈rklund A
(1990) Grafts of fetal dopamine neurons survive and improve motor
f unction in Parkinson's disease. Science 247:574 –577.
Littlewood TD, Hancock DC, Danielian PS, Parker MG, Evan GI (1995)
A modified oestrogen receptor ligand-binding domain as an improved
switch for the regulation of heterologous proteins. Nucleic Acids Res
23:1686 –1690.
Martini R (1994) E xpression and f unctional roles of neural cell surface
